Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Major Histocompatibility Complex | 4 | 2018 | 70 | 1.41 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 4 | 2017 | 154 | 1.02 | Why? |
| Genes, MHC Class I | 3 | 2018 | 81 | 1.01 | Why? |
| Zika Virus Infection | 8 | 2018 | 1920 | 0.94 | Why? |
| Simian Immunodeficiency Virus | 5 | 2017 | 251 | 0.93 | Why? |
| Flaviviridae Infections | 2 | 2017 | 27 | 0.88 | Why? |
| Macaca fascicularis | 3 | 2017 | 1009 | 0.81 | Why? |
| Zika Virus | 6 | 2018 | 1924 | 0.81 | Why? |
| Macaca nemestrina | 1 | 2017 | 71 | 0.71 | Why? |
| Gene Library | 1 | 2018 | 234 | 0.67 | Why? |
| Haplotypes | 3 | 2018 | 853 | 0.67 | Why? |
| Catheterization, Peripheral | 1 | 2020 | 249 | 0.64 | Why? |
| Histocompatibility Antigens Class I | 5 | 2018 | 624 | 0.63 | Why? |
| Alleles | 5 | 2018 | 1557 | 0.61 | Why? |
| Mosquito Vectors | 2 | 2018 | 351 | 0.60 | Why? |
| Catheterization, Central Venous | 1 | 2020 | 458 | 0.58 | Why? |
| Macaca mulatta | 10 | 2018 | 3716 | 0.53 | Why? |
| Stillbirth | 1 | 2018 | 544 | 0.52 | Why? |
| Biological Evolution | 2 | 2021 | 641 | 0.51 | Why? |
| Sports | 1 | 2021 | 690 | 0.51 | Why? |
| Abortion, Spontaneous | 1 | 2018 | 776 | 0.47 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.40 | Why? |
| Delivery of Health Care, Integrated | 1 | 2020 | 1549 | 0.36 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.35 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.34 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2021 | 3388 | 0.34 | Why? |
| Papio anubis | 2 | 2018 | 4 | 0.34 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.30 | Why? |
| Surgeons | 1 | 2020 | 2233 | 0.30 | Why? |
| Molecular Diagnostic Techniques | 2 | 2021 | 4239 | 0.29 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.29 | Why? |
| Occupational Diseases | 1 | 2020 | 2787 | 0.28 | Why? |
| Infectious Disease Transmission, Vertical | 3 | 2018 | 5164 | 0.27 | Why? |
| RNA, Viral | 6 | 2021 | 32276 | 0.27 | Why? |
| Polymerase Chain Reaction | 2 | 2017 | 6740 | 0.25 | Why? |
| T-Lymphocytes, Cytotoxic | 2 | 2004 | 552 | 0.24 | Why? |
| Viremia | 3 | 2018 | 1020 | 0.23 | Why? |
| Animals | 23 | 2021 | 78931 | 0.22 | Why? |
| Gene Frequency | 3 | 2018 | 1210 | 0.20 | Why? |
| Papio cynocephalus | 1 | 2018 | 1 | 0.19 | Why? |
| Genetic Variation | 4 | 2021 | 3919 | 0.19 | Why? |
| GB virus C | 1 | 2017 | 8 | 0.18 | Why? |
| Histocompatibility Antigens | 1 | 2017 | 38 | 0.18 | Why? |
| Immunologic Tests | 1 | 2021 | 445 | 0.18 | Why? |
| Receptors, KIR3DL1 | 1 | 2017 | 1 | 0.18 | Why? |
| Primates | 2 | 2018 | 584 | 0.18 | Why? |
| New Jersey | 1 | 2020 | 528 | 0.18 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2013 | 5837 | 0.18 | Why? |
| Angioplasty, Balloon | 1 | 2018 | 66 | 0.18 | Why? |
| Uterus | 1 | 2018 | 98 | 0.17 | Why? |
| Vena Cava, Inferior | 1 | 2018 | 103 | 0.17 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.17 | Why? |
| Breeding | 1 | 2017 | 60 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.17 | Why? |
| Aneurysm | 1 | 2018 | 117 | 0.17 | Why? |
| DNA Primers | 1 | 2020 | 1170 | 0.15 | Why? |
| Colobus | 1 | 2014 | 5 | 0.15 | Why? |
| Cercopithecus | 1 | 2014 | 7 | 0.15 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.14 | Why? |
| Cat Diseases | 1 | 2021 | 539 | 0.14 | Why? |
| Flaviviridae | 1 | 2014 | 60 | 0.14 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2018 | 492 | 0.14 | Why? |
| Aedes | 1 | 2017 | 380 | 0.14 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.14 | Why? |
| Eye | 1 | 2018 | 374 | 0.13 | Why? |
| Disease Models, Animal | 4 | 2020 | 10998 | 0.12 | Why? |
| Endemic Diseases | 1 | 2017 | 480 | 0.12 | Why? |
| Viral Tropism | 2 | 2018 | 1329 | 0.12 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2013 | 325 | 0.12 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.12 | Why? |
| Monkey Diseases | 1 | 2014 | 190 | 0.12 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.12 | Why? |
| Macaca | 1 | 2013 | 388 | 0.12 | Why? |
| Program Evaluation | 1 | 2020 | 1929 | 0.11 | Why? |
| Sequence Analysis, RNA | 1 | 2020 | 2290 | 0.11 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.11 | Why? |
| Personnel Staffing and Scheduling | 1 | 2020 | 1578 | 0.11 | Why? |
| Epitopes | 1 | 2003 | 4113 | 0.11 | Why? |
| HIV | 1 | 2017 | 1116 | 0.10 | Why? |
| Amino Acid Sequence | 2 | 2017 | 6049 | 0.10 | Why? |
| Placenta | 2 | 2018 | 1531 | 0.10 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.10 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.10 | Why? |
| Workload | 1 | 2020 | 1887 | 0.10 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.10 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.09 | Why? |
| Oropharynx | 1 | 2017 | 1581 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Antibody Formation | 2 | 2017 | 4038 | 0.09 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Primate Diseases | 2 | 2017 | 110 | 0.08 | Why? |
| Mauritius | 1 | 2005 | 43 | 0.08 | Why? |
| Universities | 1 | 2021 | 4374 | 0.08 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.07 | Why? |
| Interferon-gamma | 2 | 2013 | 2711 | 0.07 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Pregnancy | 4 | 2018 | 23879 | 0.06 | Why? |
| Genome, Viral | 3 | 2021 | 13157 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Phylogeny | 5 | 2021 | 13341 | 0.06 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| X-Ray Microtomography | 1 | 2021 | 115 | 0.06 | Why? |
| Humans | 18 | 2021 | 930598 | 0.05 | Why? |
| Saliva | 1 | 2017 | 4679 | 0.05 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Adaptation, Biological | 1 | 2021 | 179 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Phlebography | 1 | 2018 | 65 | 0.05 | Why? |
| Wisconsin | 1 | 2020 | 607 | 0.05 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 7868 | 0.04 | Why? |
| Decidua | 1 | 2017 | 32 | 0.04 | Why? |
| Nervous System Malformations | 1 | 2017 | 43 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.04 | Why? |
| Evolution, Molecular | 2 | 2021 | 3691 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Animals, Newborn | 1 | 2018 | 350 | 0.04 | Why? |
| Cell Degranulation | 1 | 2017 | 130 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2018 | 207 | 0.04 | Why? |
| Selection, Genetic | 1 | 2021 | 691 | 0.04 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.04 | Why? |
| Lymphoid Tissue | 1 | 2017 | 162 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Americas | 1 | 2017 | 418 | 0.04 | Why? |
| Fetal Development | 1 | 2017 | 173 | 0.04 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.04 | Why? |
| Leukocytes, Mononuclear | 1 | 2005 | 2115 | 0.04 | Why? |
| Amniotic Fluid | 1 | 2017 | 249 | 0.04 | Why? |
| Microarray Analysis | 1 | 2017 | 262 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2020 | 1638 | 0.04 | Why? |
| Protein Array Analysis | 1 | 2017 | 387 | 0.04 | Why? |
| Umbilical Cord | 1 | 2017 | 358 | 0.04 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.03 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Cells, Cultured | 1 | 2005 | 5835 | 0.03 | Why? |
| Cats | 1 | 2021 | 1890 | 0.03 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 511 | 0.03 | Why? |
| Fetus | 1 | 2017 | 484 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2004 | 2262 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2021 | 1267 | 0.03 | Why? |
| Vietnam | 1 | 2018 | 1665 | 0.03 | Why? |
| Spleen | 1 | 2017 | 877 | 0.03 | Why? |
| Virion | 1 | 2021 | 1444 | 0.03 | Why? |
| Genes, Viral | 1 | 2018 | 1428 | 0.03 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2020 | 1138 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| Equipment Design | 1 | 2021 | 3095 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.03 | Why? |
| Asia | 1 | 2017 | 2399 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| China | 1 | 2017 | 50654 | 0.02 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Respiratory Protective Devices | 1 | 2020 | 1637 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Africa | 1 | 2017 | 2986 | 0.02 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| United States | 2 | 2021 | 46150 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.02 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.01 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Vero Cells | 1 | 2017 | 14117 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Lung | 2 | 2021 | 31049 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.01 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2017 | 29620 | 0.01 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |